Roche H1N1 flu test wins emergency clearance
This article was originally published in The Gray Sheet
FDA grants emergency use authorization to Roche's RealTime Ready Influenza A/H1N1 Detection Set,which will allow clinicians to test for the presence of the 2009 H1N1 influenza virus collected via nasopharyngeal swabs, nasal swabs, washes and aspirates in clinical settings, and "augment existing testing capacity" for the H1N1 virus, FDA says in its Nov. 13 EUA letter. FDA has also granted emergency use authorization for use of Roche's Detection Set on the company's LightCycler 2.0 ("1The Gray Sheet" Aug. 24, 2009)
You may also be interested in...
With an especially challenging flu season expected this year, government officials are scrambling to evaluate the tools they have available to monitor, diagnose and limit spread of the virus
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.